$P

Yen Mallun sold $364K of P

Yen Mallun sold 4,735 shares of Everpure, Inc. (P) at $76.90 ($0.36M total) on 2026-06-22.

Original reporting
SEC EDGAR · Yen Mallun
Published Jun 24, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 6:50 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$P
Neutral
low confidence
Mentioned
$P
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PNeutralLow
01

Why it matters

The disclosed open-market sale reduces the director’s direct holdings to 43,281 shares, but the filing provides no operational or financial update for Everpure.

02

Market read

This is primarily a sentiment datapoint from insider selling, with low likelihood of driving price without additional company catalysts.

03

What to watch

Traders should check whether there are multiple consecutive insider sales, changes in ownership concentration, or concurrent company disclosures; this article alone provides only one transaction.

Relevance 4/10Novelty 3/10Timing: filed 2026-06-24, covering sale dated 2026-06-22

Background

The article is an SEC Form 4 insider transaction disclosure for Everpure, Inc. (director Yen Mallun).

Company-level read

Ticker impact

$PNeutralLow confidence
Context

Everpure director Yen Mallun filed a Form 4 for an open-market sale of 4,735 shares at $76.90 on 2026-06-22.

Expected impact

Likely limited near-term impact; any effect would be sentiment-only unless follow-on filings show sustained selling.

Evidence & confidence

Form 4 insider transactions are common and often non-informational; the filing lacks any accompanying company-specific news or performance change.

Market effects

No sector-level implications; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

The absence of a disclosed 10b5-1 plan does not necessarily imply bearish information; sales can be for diversification, taxes, or pre-existing personal liquidity needs.

Key entities

  • Everpure, Inc.

    Company whose director insider sale is disclosed via SEC Form 4.

  • Yen Mallun

    Director who sold 4,735 shares at $76.90 per share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PHighAI 8/10

Everpure Stock Surges As S&P 500 Inclusion Fuels Breakout

Everpure Inc. (NYSE: P) stock rose 4.48% after positive product coverage and S&P 500 inclusion. The company reaffirmed its 2027 outlook and provided 2028 targets above expectations. Everpure reported $3.66B revenue, 70.2% gross margin, and a P/E ratio of 496. Its inclusion in the S&P 500 is expected to drive structural demand.

$PHigh

Everpure Stock Surges As 2027–2028 Guidance Fuels Breakout

Everpure Inc. (NYSE: P) shares rose 4.48% on October 7, 2026, after reaffirming its 2027 guidance and providing 2028 targets exceeding Wall Street expectations. The company expects $940–$960M in adjusted operating income and $5.03–$5.07B in revenue for 2027. Everpure is also being added to the S&P 500, which may drive further demand. The stock trades at a P/E of 496 and has seen significant momentum, reaching $152.66 from the mid-$90s in recent weeks.

$PHighAI 8/10

Everpure (P) Shares Rise After CFRA Upgrade and Strong Fiscal 20

Everpure Inc (NYSE: P) shares rose 3% after CFRA upgraded it from Sell to Buy, citing raised guidance for fiscal 2028. The company projects $7B-$7.3B in revenue and $1.7B-$1.9B in non-GAAP operating income, driven by demand for its all-flash storage solutions in AI data centers. Despite this, GuruFocus's GF Value™ suggests the stock is overvalued at $126.00, with an intrinsic value of $81.40.

$METAMedAI 8/10

Meta, Everpure, Akamai Technologies, Apimeds Pharmaceuticals and Costco: Why These 5 Stocks Are on Invest

Meta (META) rose 4.5% to $777.59, driven by AI strategy. Everpure (P) surged 11.15% to $121.88, reaffirming fiscal 2027 guidance. Akamai (AKAM) fell 6.78% to $110.41, then jumped 20.65% after-hours on a $11.6B AI deal. Apimeds (APUS) soared 114.85% to $4.92 on a blockchain agreement. Costco (COST) dipped 0.91% to $896.48 despite beating Q4 estimates.

$PHighAI 8/10

Everpure Stock Jumps As S&P 500 Inclusion Fuels Momentum

Everpure Inc. (NYSE: P) stock rose 12.77% after its inclusion in the S&P 500. The company's shares have climbed from the low-$90s to $121.88, with a high of $131.41. Everpure reported $3.66B in annual revenue, 70.2% gross margins, and a P/E above 380. The S&P 500 inclusion is expected to drive passive fund buying.